TickerFactsScreenerDevelopers

Aptevo Therapeutics Inc. (APVO) — Operating Income

Annual figures by fiscal year, from SEC filings.

2015: -$61.10M2016: -$138.77M2017: -$53.95M2018: -$51.66M2019: -$40.96M2020: -$27.49M2021: -$21.40M2022: -$28.64M2023: -$28.88M2024: -$24.60M2025: -$26.31M-$26.31M
2015Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$26.31M-7.0%
2024-$24.60M+14.8%
2023-$28.88M-0.8%
2022-$28.64M-33.8%
2021-$21.40M+22.2%
2020-$27.49M+32.9%
2019-$40.96M+20.7%
2018-$51.66M+4.2%
2017-$53.95M+61.1%
2016-$138.77M-127.1%
2015-$61.10M—